Macro Group Pharmaceuticals (Macro Capital) S.A.E

EGX-MCRO
Egyptian Stock Exchange
Perfumes, Cosmetics, and Other Toilet Preparations
Global Rank
#41518
Country Rank
#195
Market Cap
10.09 M
Price
0.0177
Change (%)
7.71%
Volume
38.98 M

EGX-MCRO's Next Dividend

Next Estimated Amount
0.107
Next Estimated Pay Date
05/04/2025
Last Amount
0.107
Last Pay Date
10/31/2023
Dividend Shot Clock Ex-Date: 04/18/2023
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

Macro Group Pharmaceuticals (Macro Capital) S.A.E Dividend Chart

*Amounts are shown in the stock exchange currency (EGP) for convenience

Macro Group Pharmaceuticals (Macro Capital) S.A.E(EGX-MCRO) Dividend History

Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX-MCRO) currently pays an annual dividend of $0.00 per share, offering a dividend yield of 3.13%. The next dividend payout date has not been announced.
Ex-Dividend Date Amount Adj. Amount Dividend Yield Pay Date Change (%)
2023 0.107 0.107 55%
04/18/2023 0.107 0.107 3.13% 10/31/2023 55%
2022 0.069 0.069
04/26/2022 0.069 0.069 1.85% 04/28/2022
*Amounts are shown in the stock exchange currency (EGP) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.